Gerald M Devins1. 1. Ontario Cancer Institute, Princess Margaret Hospital, and University of Toronto, Canada. gdevins@uhnres.utoronto.ca
Abstract
OBJECTIVE: Illness intrusiveness is a common, underlying determinant of quality of life in people affected by chronic disease. Illness intrusiveness results from disease- and treatment-induced disruptions to lifestyles, activities, and interests (i.e., interference with psychologically meaningful activity). This paper introduces the Illness Intrusiveness Ratings Scale (IIRS), a 13-item, self-report instrument. The IIRS can be scored to generate a total score or three subscale scores: relationships and personal development, intimacy, and instrumental. In addition to describing the IIRS, the paper presents the theoretical framework in which it is anchored, reviews the evidence, and reports psychometric properties. METHODS: Qualitative literature review. RESULTS: Findings support the IIRS's reliability (internal consistency and test-retest), validity (construct, criterion-related, and discriminant), sensitivity to change, and factorial invariance across numerous chronic-disease groups. The paper reports IIRS reliability coefficients and normative statistics for 36 chronic, medical and psychiatric patient populations. CONCLUSION: The IIRS taps the extent to which disease- and treatment-related factors interfere with psychologically meaningful activity among people affected by chronic disease. It provides a valid, reliable measure that is easy to administer and unequivocally interpretable rendering it suitable for research designed to estimate the psychosocial impact of chronic disease and to document (and compare) the effectiveness of therapeutic interventions. Copyright 2010 Elsevier Inc. All rights reserved.
OBJECTIVE:Illness intrusiveness is a common, underlying determinant of quality of life in people affected by chronic disease. Illness intrusiveness results from disease- and treatment-induced disruptions to lifestyles, activities, and interests (i.e., interference with psychologically meaningful activity). This paper introduces the Illness Intrusiveness Ratings Scale (IIRS), a 13-item, self-report instrument. The IIRS can be scored to generate a total score or three subscale scores: relationships and personal development, intimacy, and instrumental. In addition to describing the IIRS, the paper presents the theoretical framework in which it is anchored, reviews the evidence, and reports psychometric properties. METHODS: Qualitative literature review. RESULTS: Findings support the IIRS's reliability (internal consistency and test-retest), validity (construct, criterion-related, and discriminant), sensitivity to change, and factorial invariance across numerous chronic-disease groups. The paper reports IIRS reliability coefficients and normative statistics for 36 chronic, medical and psychiatricpatient populations. CONCLUSION: The IIRS taps the extent to which disease- and treatment-related factors interfere with psychologically meaningful activity among people affected by chronic disease. It provides a valid, reliable measure that is easy to administer and unequivocally interpretable rendering it suitable for research designed to estimate the psychosocial impact of chronic disease and to document (and compare) the effectiveness of therapeutic interventions. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: Lisa M McTeague; Peter J Lang; Bethany C Wangelin; Marie-Claude Laplante; Margaret M Bradley Journal: Biol Psychiatry Date: 2012-03-03 Impact factor: 13.382
Authors: Gerald M Devins; Kenneth Mah; Hans A Messner; Anargyros Xenocostas; Lise Gauvin; Jeffrey H Lipton Journal: Support Care Cancer Date: 2018-02-08 Impact factor: 3.603
Authors: Suzanne C Danhauer; Greg Russell; L Douglas Case; Stephanie J Sohl; Richard G Tedeschi; Elizabeth L Addington; Kelli Triplett; Kimberly J Van Zee; Elizabeth Z Naftalis; Beverly Levine; Nancy E Avis Journal: Ann Behav Med Date: 2015-10
Authors: Neha G Goyal; Beverly J Levine; Kimberly J Van Zee; Elizabeth Naftalis; Nancy E Avis Journal: Breast Cancer Res Treat Date: 2018-01-24 Impact factor: 4.872
Authors: Nancy E Avis; Beverly Levine; Michelle J Naughton; L Douglas Case; Elizabeth Naftalis; Kimberly J Van Zee Journal: Breast Cancer Res Treat Date: 2013-04-16 Impact factor: 4.872